tiprankstipranks

Joseph E Gilliam Insider Profile

4 Followers
Joseph E Gilliam, Director at Caris Life Sciences, Inc., holds 29.32K shares in Caris Life Sciences, Inc. (Ticker: CAI), holds 72.59K shares in Glaukos (Ticker: GKOS).
tipranks
Joseph E Gilliam

Joseph E Gilliam
Caris Life Sciences, Inc. (CAI)
Director

Ranked #65,368 out of 108,575 Corporate Insiders

Profitable Transactions

40%
2 out of 5 Profitable Transactions

Average Return

-5.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$14M
95.45%
4.55%
A breakdown of Joseph E Gilliam's holdings

Insider Roles

Glaukos
(GKOS)
PRESIDENT & COO
Caris Life Sciences, Inc.
(CAI)
Director
Roles that Joseph E Gilliam holds in companies

Most Profitable Insider Trade

Stock:
Glaukos
(GKOS)
Rating:Informative Buy
Date:Nov 27, 2017 - Nov 27, 2018
Return:+128.50%
The most profitable trade made by Joseph E Gilliam

Joseph E Gilliam's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Caris Life Sciences, Inc.
Aug 14, 2026
Director
Uninformative Buy
$639.20K
Glaukos
Aug 13, 2026
PRESIDENT & COO
Uninformative Buy
3.18M
$13.39M
List of latest transactions for each holding click on a transaction to see Joseph E Gilliam's performance on stock

Joseph E Gilliam insider profile FAQ

What is the percentage of profitable transactions made by Joseph E Gilliam?
The percentage of profitable transactions made by Joseph E Gilliam is 40%.
    What is the average return per transaction made by Joseph E Gilliam?
    The average return per transaction made by Joseph E Gilliam is -5.80%.
      What stocks does Joseph E Gilliam hold?
      Joseph E Gilliam holds: CAI, GKOS stocks.
        What was Joseph E Gilliam’s latest transaction?
        Joseph E Gilliam latest transaction was an Uninformative Buy of ―.
          What was Joseph E Gilliam's most profitable transaction?
          Joseph E Gilliam’s most profitable transaction was an Informative Buy of GKOS stock on November 27, 2017. The return on the trade was 128.50%.
            What is Joseph E Gilliam's role in Caris Life Sciences, Inc.?
            Joseph E Gilliam's role in Caris Life Sciences, Inc. is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.